About the authors
From the following article:
Cancer-related anemia and recombinant human erythropoietin—an updated overview
Julia Bohlius, Olaf Weingart, Sven Trelle and Andreas Engert
BACK TO ARTICLEJulia Bohlius
Dr Julia Bohlius gained her medical degree in 1999 from Hamburg University, Germany. She holds a doctoral degree in Medicine from the University of Cologne and obtained a Master of Public Health Sciences at the London School of Hygiene and Tropical Medicine, UK. Currently, Dr Bohlius is research fellow at the Cochrane Hematological Malignancies Group at the Department I of Internal Medicine at the University of Cologne. She has published systematic reviews and is involved in the development of clinical guidelines.
Olaf Weingart
Dr Olaf Weingart received his medical degree in 1994. He then worked in several hospitals for internal medicine and in ambulatory care in Germany and Switzerland. Since 2000, he is a qualified physician in general practice and has since worked in the field of evidence-based medicine at the German Guideline Clearinghouse. Since 2004, he is based at the Cochrane Haematological Malignancies Group at the Department of Oncology University of Cologne.
Sven Trelle
Dr Sven Trelle gained his medical degree in 2002 at the University of Hamburg, Germany. He worked at the Department I of Internal Medicine at the University of Cologne, Germany from 2003 to 2005 and is currently a member of the Cochrane Haematological Malignancies Group. Since 2006, he is with the Division of Epidemiology and Biostatistics, Department of Social and Preventive Medicine at the University of Berne, Switzerland.
Andreas Engert
Professor Dr Andreas Engert gained his medical degree in 1985 at the University of Hannover, Germany. From 1988 to 1990 he worked at the Imperial Cancer Research Fund in London on antibody-based lymphoid cancer immunotherapy. After returning to the Medical Department in Cologne he continued his research and clinical activities in the treatment of hematological malignancies. He has published more than 130 original papers. Professor Engert is secretary of the German Hodgkin Study Group and coordinating editor of the Cochrane Hematological Malignancies Group. He is senior consultant at the Medical Department I at the University of Cologne.